Erika Parasido - Concepedia

Author

Erika Parasido

Georgetown University

Also Known As

E. M. Parasido, Erika M. Parasido, Erika Maria Parasido, Erika Parasido, Parasido, Erika, Parasido, Erika Maria <1985>

Publications

606

Citations

H-Index

Concepts

All Affiliations

Georgetown University Georgetown University Medical Center George Mason University North Carolina Central University Massachusetts General Hospital

About

Erika Parasido is an author at Georgetown University specializing in tumor biology, oncology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	170
2	Cell Biology	1	1	137
3	Pathology	1	1	33
4	Pharmacology	1	1	33
5	Cancer Therapeutics	1	1	33

Erika Parasido

Publications

558

Citations

H-Index

Page 1

	Year	Citations
The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer Harvey R. Fernandez, Shreyas M. Gadre, Mingjun Tan, Cell Death and Differentiation Lung CscsMetabolic RemodelingCancer BiologyTumor BiologyOncology	2018	137
Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH Mingjun Tan, Rami Mosaoa, Garrett T. Graham, Cell Death and Differentiation	2020	126
The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma Cells Erika Parasido, George Avetian, Aisha Naeem, Molecular Cancer Research	2019	83
The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells Lymor Ringer, Paul Sirajuddin, Lucas Tricoli, Oncotarget	2014	42
Pilot Phase I/II Personalized Therapy Trial for Metastatic Colorectal Cancer: Evaluating the Feasibility of Protein Pathway Activation Mapping for Stratifying Patients to Therapy with Imatinib and Panitumumab Mariaelena Pierobon, Alessandra Silvestri, Alexander I. Spira, Journal of Proteome Research Reverse-phase Protein ArrayControl ArmsMedicinePharmacologyColorectal Cancer	2014	33
Thermoresponsive release of viable microfiltrated Circulating Tumor Cells (CTCs) for precision medicine applications Zheng Ao, Erika Parasido, Siddarth Rawal, Lab on a Chip	2015	28
The p53 tumor suppressor protein protects against chemotherapeutic stress and apoptosis in human medulloblastoma cells Sarah Waye, Aisha Naeem, Muhammad Umer Choudhry, Aging	2015	23
Characterization of the effects of defined, multidimensional culture conditions on conditionally reprogrammed primary human prostate cells Lucas Tricoli, Aisha Naeem, Erika Parasido, Oncotarget	2017	20
Clinicopathologic and Prognostic Significance of LGR5, a Cancer Stem Cell Marker in Patients With Colorectal Cancer Chukwuemeka Ihemelandu, Aisha Naeem, Erika Parasido, Colorectal Cancer	2019	17
Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient‐derived primary prostate cells Aisha Naeem, Sivanesan Dakshanamurthy, Henry Walthieu, The Prostate	2020	15

Page 1